Jerry Dixon connects B2B companies the moment a public trigger fires — an FDA letter, a hiring surge, a campaign in production — with the operators built for exactly that moment.
Public trigger data across B2B, FDA enforcement, hiring, and production — updated as it publishes.
- →5 warning letters posted by FDA this month — CGMP and misbranding cases across pharma and device makers, including Reliance Life Sciences and Jabil
- →USCIS closed the FY2027 H-1B cap in July — no second lottery, leaving sponsored hiring surges stalled
- →ISM Services PMI hit 55.4% in August — the 26th straight month of B2B growth
- →ISM Manufacturing PMI held at 54.6% in August — an 8th straight month of production expansion
Sourced from FDA.gov warning letters, USCIS.gov, and ISM PMI reports.
No deal to point at yet — so here’s exactly what I put in motion.
- Public trigger → operator already positioned When an FDA letter, a hiring surge, or a production campaign goes public, I move inside the days that follow — before the company starts its own search from zero.
- Ready for the moment → not just qualified on paper I match on fit to the specific trigger, not the biggest name in the room — the operator built for this exact shape of problem, not just any operator who "does" it.
Building in the open. I’m working alongside myoProcess — a vetted B2B partner trusted across $1B+ in transactions — while I route my first introductions in this lane. My first closed match replaces this paragraph.
What I see in this market that outsiders miss.